Name: Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)
Price: 76590.00 CLP
Availability: InStock
Author: Philip A. Rea; Mark V. Pauly; Lawton R. Burns
ISBN: 9781107577305

portada Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)

Formato

Libro Físico

Editorial

Cambridge University Press

Autor

Philip A. Rea; Mark V. Pauly; Lawton R. Burns

Año

2018

Idioma

Inglés

N° páginas

554

Encuadernación

Tapa Blanda

ISBN13

9781107577305

Categorías

Investigación médica

Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)

Philip A. Rea; Mark V. Pauly; Lawton R. Burns (Autor) · Cambridge University Press · Tapa Blanda

Libro Nuevo

$ 76.590

$ 117.830

Ahorras: $ 41.240

35% descuento

Cantidad
Estado: Nuevo
Quedan 50 unidades

Envío normal

Origen: España (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 09 de Mayo y el Jueves 16 de Mayo.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (en Inglés)"

In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.